抗凝溶栓药物治疗血管疾病中出血风险评估及处理

蒋米尔,刘 光

中国实用外科杂志 ›› 2011, Vol. 31 ›› Issue (12) : 1095-1098.

PDF(477 KB)
PDF(477 KB)
中国实用外科杂志 ›› 2011, Vol. 31 ›› Issue (12) : 1095-1098.
专题笔谈

抗凝溶栓药物治疗血管疾病中出血风险评估及处理

  • 蒋米尔,刘    光
作者信息 +
文章历史 +

摘要

抗凝和溶栓治疗在血管外科中被广泛应用于防治血栓(栓塞)形成和(或)复发,然而,这些药物所带来的出血风险不容忽视。准确评估病人的出血风险,选择合理有效的药物,定期规律的监测,及时快速的处理是在使用抗凝溶栓药物过程中所要遵守的操作规程。

Abstract

The bleeding risk assessment and treatment strategies of anticoagulant and thrombolytic drugs        JIANG Mi-er, LIU Guang. Department of Vascular Surgery, Shanghai Ninth People’s Hospital Affiliated Shanghai Jiao Tong University School of Medicine, Shanghai200011, China
Corresponding author:JIANG Mi-er,E-mail:jiangme2005@yahoo.com.cn
Abstract    Anticoagulant and thrombolytic therapy have been widely applied in the treatment or prevention for thrombosis (embolism) and /or recurrence in vascular surgery. However, the risk of bleeding caused by the drugs could not be ignored. The bleeding risk assessment and treatment strategies of anticoagulant and thrombolytic drugs should be implemented.

关键词

抗凝药 / 溶栓药 / 出血 / 风险评估 / 处理对策

Key words

anticoagulant drugs / thrombolytic drugs / bleeding / risk assessment / treatment strategy

引用本文

导出引用
蒋米尔,刘 光. 抗凝溶栓药物治疗血管疾病中出血风险评估及处理[J]. 中国实用外科杂志. 2011, 31(12): 1095-1098

PDF(477 KB)

Accesses

Citation

Detail

段落导航
相关文章

/